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Molecular theranostics in cancer metastasis 
1Chung Leland W. K., 1Yang Xiaojian, 2Tong Rong, 2Cheng Jianjun, 1Wang 
Ruoxiang and 1Zhau Haiyen E. 
1Uro-Oncology Research Program, Department of Medicine, Samuel Oschin Comprehensive Cancer 
Institute, Cedars-Sinai Medical Center; Los Angeles, CA 90048, USA;  
2Department of Materials Science and Engineering, University of Illinois, Urbana, IL61801, USA 
Leland.Chung@cshs.org 
Background: Cancer metastases are the major contributing factors to the lethality and 
morbidity of the patients. Thus far the majority of the new-targeted therapies are 
designed based on our understanding of inter- and intra-cellular signaling pathways 
between and within cancer cells and the unique biology of organ-specific expression of 
molecular targets. Since the mortality of cancer has not been improved significantly, new 
approaches are needed to reduce the occurrence and the progression of human cancer. In 
this context, we have developed a novel class of near infrared (NIR) organic 
heptamethine cyanine dyes (HMCD), which has unique properties of uptake and 
retention in cancer but not normal cells. We prepared chemical conjugates of these dyes 
and found them to be ideal theranostic agents for cancer imaging and therapy. These 
compounds are tested for their ability to eradicate prostate cancer growth and metastases 
in mouse models.   
Objectives: We seek to achieve the following three objectives: 1) to develop a class of 
effective HMCD to image cancer cells; 2) to modify chemically HMCD to create a new 
class of theranostic agents for dual imaging and targeting of cancer cells in culture; and 
3) to investigate the effectiveness of systemic HMCD-drug conjugates to eradicate 
preexisting prostate tumors grown in mice either at subcutaneous space or in mouse tibia.  
 Results: MHI-148 and IR-783 are non-toxic and effective imaging agents for human 
cancer cells in culture and human tumor xenografts in mice; a close structural analogy of 
the IR-783, the IR-780, was found to be less effective and more toxic.  MHI-148 and IR-
783 uptake into cancer cells through an organic anion transporter-mediated mechanism. 
We employed these dyes as carriers for the therapeutic drugs, which were covalently 
conjugated to the dyes to create novel theranostic agents. We synthesized two prototypes 
of dye-docetaxel conjugates, IR-MUT-1 and IR-MUT-2, and found both of these dye-
drug conjugates highly effective against the growth of prostate cancer cells in culture and 
prostate tumor xenografts grown either subcutaneously or intratibially in mice.    
Conclusion: A new class of HMCD-based imaging and targeting theranostic agents has 
been synthesized and tested in human cancer cells and human tumor xenografts. These 
conjugates were found to retain in tumor but not in normal tissues and exert cytotoxic 
effects against the growth of human tumor but not the regression of normal tissues. This 
class of novel theranostic agents may be applicable in human for the eradication of 
cancer and cancer metastases.  
Supported by NIH 2P01CA098912 and Endowed Chair Fund). 
 40 
Thiazolidinone motif in anticancer drug discovery. Experience of 
DH LNMU medicinal chemistry scientific group 
Lesyk R.B., Zimenkovsky B.S., Kaminskyy D.V., Kryshchyshyn A.P., Havryluk 
D.Ya., Atamanyuk D.V., Subtel’na I.Y., Khyluk D.V. 
 
Department of Pharmaceutical, Organic and Bioorganic Chemistry,  
Danylo Halytsky Lviv National Medical University,  
69, Pekarska St. Lviv, Ukraine, 79010 
 
dr_r_lesyk@org.lviv.net; dankaminskyy@gmail.com 
Background. Recently 4-thiazolidinone and related systems research area unexpectedly 
became interesting and promising in oncology field. The success in anticancer agents 
search among 4-thiazoldinones derivatives realized in identification the rows of 
molecular mechanisms and biological targets of mentioned compounds antitumor action. 
Discovery of new biological active compounds base on azolidinones and related systems 
refer to one of the most successful project of DH LNMU. It is based on 3 strategic 
vectors: organic synthesis, pharmacological research, rational design of “drug-like” 
molecules ((Q)SAR-analysis, molecular docking etc.) In spite of the series of perspective 
results, progress of the project brings to some research directions changes, notably it has 
focused on the search of new anticancer agents. 
The aim was formation of some rational design directions of potential anticancer agents 
base on the 4-thiazolidinones and related heterocyclic systems anticancer activity data 
analysis. 
Results. Synthetic research carried out in DH LNMU allowed us to propose a whole 
number of new chemical directions of biological active 4-thiazolidinones and related 
heterocyclic systems design and obtain directed library that numbers over 5000 of novel 
compounds. In vitro anticancer activity screening was carried out for more than 1000 
compounds (DTP NCI protocol), among them 167 compounds showed high antitumor 
activity with low toxicity level. The desirable molecular fragments with crucial influence 
on activity level as well as main position for structure modification of core rings in each 
of synthesized 4-thiazolidinones sub-libraries were determined base on SAR analysis. For 
the purpose of optimization and rational design of highly active molecules with optimal 
“drug-like” characteristics, building the prediction models and discovering of possible 
molecular mechanisms of action QSAR, COMPARE analysis and molecular docking 
were carried out. 
Conclusion. Based on systematic combination of pharmacological screening methods 
and in silico data the anticancer activity is determined as privileged for thiazolidinones 
and related heterocyclic systems that allowed identification of “hit-compounds” series. 
Some aspects of structure-activity relationships were determined in 4-thiazolidionones 
derivatives sub-libraries and structure rational design directions of anticancer agents were 
proposed. Among tested compounds 167 samples showed high antitumor activity level 
and their in-depth preclinical studies are in progress. 
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Candidate SEREX-identified antigens for detection of breast cancer 
autoantibody profile 
1,2Kostianets О. I., 1,2Shyian M. A., 2Demidov S. V., 1Filonenko V. V.,  
1Kiyamova R. G.   
1 Institute of Molecular Biology and Genetics of the NAS of Ukraine,  
150, Zabolotnogo St., Kyiv, Ukraine, 03680 
2 Taras Shevchenko National University of Kyiv, Kyiv, Ukraine 
64, Volodymyrska St. Kyiv, Ukraine, 01033 
 
kostjanez@ukr.net; filonenko@imbg.org.ua 
 
Autoantibodies to tumor-associated antigens can serve as reporters of molecular changes 
associated with cell transformation, which in turn opens up new possibilities for 
diagnosis, prognosis and monitoring of cancer. The production of autoantibodies reflects 
the immune response to a continuous remodeling of cells or tissues caused by a cell 
transformation process. The antibodies are the most appropriate cancer diagnostic tools, 
since these molecules are very stable, and its nano- and pico-molar concentration can be 
detected at the early stages of pathological process, including tumorogenesis, even before 
the onset of clinical symptoms. 
The aim of our study was to identify and characterize novel tumor-associated antigens of 
medullary breast carcinoma (MBC) for the creation of test system for monitoring of 
autoantibody “signature” for diagnostics and prognosis of different types of breast 
cancer.  
Medullary breast carcinoma despite the high degree of malignancy has a good prognosis 
for patients and characterized by heavily lymphocytic infiltration, that makes it an ideal 
target to search for tumor-associated antigens of breast cancer. In the course of this study 
using a modified SEREX methodology we have identified 42 genes, which products are 
involved in different cellular processes. Preliminary allogenic screening by phage 
expressed system allowed us to select 12 antigens for verification them as potential 
tumor-associated antigens in expanded allogenic screening in ELISA format. Up to date 
five MBC antigens were cloned, expressed, purified in bacteria and tested in ELISA with 
sera of breast cancer patients (n=18) and healthy donors (n=10). Increased levels of 
autoantibodies against three of them (RAD50, HMGN2, PDCL) were confirmed in sera 
of cancer patients compared with the control group. RAD50 (human Rad50 homolog of 
Saccharomyces cerevisiae), HMGN2 (high-mobility group nucleosomal binding domain 
2) and PDCL (Phosducin-like protein) proteins have intracellular localization and are 
likely attacked by B-cells due to necrosis or apoptosis of cancer cells.  
For creation of representative test-system for detecting of antibody “signature” with 
sufficient sensitivity and specificity more than three antigens should be included in this 
antigenic panel. So, further investigations of immunogenicity of the rest of MBC antigens 
should be continued in large scale ELISA screening. 
  43
Adaptor protein RUK/CIN85 influences hypoxia-inducible factor 1 
alpha stability in tumor cells 
1Kozlova N., 1Samoylenko A., 2Kietzmann T., 1Drobot L. 
1Palladin Institute of Biochemisry, National Academy of Sciences of Ukraine,  
9, Leontovycha Str., Kyiv, Ukraine, 01601 
2University of Oulu, Oulu, Finland 
kozlovanina@gmail.com  
 
Tumor hypoxia is a well-known micro environmental factor that causes cancer progression 
and resistance to cancer treatment. Such hypoxia is due to limited amount of vasculature, 
leaky or otherwise poorly functional tumor vessels with chaotic architecture. This involves 
multiple mechanisms, which are mediated through transcriptional gene activation by the 
hypoxia inducible factors (HIFs). Hypoxia-inducible factor-1 (HIF-1) is a DNA-binding 
protein that regulates transcription of a number of genes involved in maintaining biological 
homeostasis. HIF-1 is a heterodimer composed of an oxygen-destructible α-subunit and a β-
subunit, levels of which are not dependent on the presence of oxygen. While the existing 
body of work provides a general picture of hypoxia-dependent gene expression, the roles 
played by individual molecular components are uncertain. We recently demonstrated that 
SH3 domain-containing adaptor/scaffold protein Ruk/CIN85 could induce the expression of 
plasminogen activator inhibitor-1 (PAI-1) gene via HIF-1. The aim of present study was to 
characterize the mechanisms by which Ruk/CIN85 influences HIF-1alpha-dependent gene 
expression. It was shown that transient as well as stable overexpression of Ruk/CIN85 
induced HIF-1alpha protein levels and HIF-1 activity, while knocking down Ruk/CIN85 
reversed these effects. To investigate whether Ruk/CIN85 may interfere with HIF-1α 
stabilization or transactivation, the cells were co-transfected with the luciferase reporter 
construct pG5-E1B-Luc that contains 5 copies of a Gal4 response element and vectors 
allowing expression of fusion proteins consisting of the Gal4-DNA binding domain (Gal4) 
and either HIF-1α N-terminal (TADN) or C-terminal (TADC) transactivation domains along 
with the Ruk/CIN85 expression vector. It was found that Ruk/CIN85 interfered with the 
prolyl hydroxylation-dependent HIF-1α protein destabilization but not with asparagine 
hydroxylation-dependent HIF-1α transactivation. It is well established, that HIFs are 
regulated in response to oxygen availability by a family of iron- and 2-oxoglutarate-
dependent dioxygenases, the HIF prolyl hydroxylases (PHDs). PHDs inactivate HIFs in 
normoxia by activating degradation of the HIF-α subunit but release HIF activation in poorly 
oxygenated conditions. Since it was found that Ruk/CIN85 interfered with the prolyl 
hydroxylation-dependent HIF-1α protein destabilisation, we next investigated whether 
Ruk/CIN85 may interact directly with PHDs. By using co-immunoprecipitation assays it was 
shown that Ruk/CIN85 forms complex with PHD2. In conclusion our data show that 
Ruk/CIN85 is involved in modulation of the effects of hypoxia in tumour cells. Due to the 
fact that hypoxia is a well-known factor that causes resistance to cancer therapy, namely 
radiation therapy and also chemotherapy, and since Ruk/CIN85 influences HIF-1 alpha 
stability, it may be a potential agent in cancer targeting therapy. 
This work was supported by collaborative experimental scholarship for Central & Eastern 
Europe from Federation of European Biochemical Societies (FEBS). 
 44 
Analysis of potential ovarian cancer biomarker NaPi2b (SLC34A2) 
expression in ovarian cancer 
 
1,2Shyian M. A., 1Gryshkova V. S., 1,2Kostianets O. I.  1Filonenko V. V.,  
1Kiyamova R. G. 
 
1 Institute of Molecular Biology and Genetics, NAS of Ukraine, Kyiv, Ukraine  
150, Zabolotnogo St., Kyiv, Ukraine, 03680 
2 Taras Shevchenko National University of Kyiv, Kyiv, Ukraine 
64, Volodymyrska St. Kyiv, Ukraine, 01033 
 
m.a.shyyan@gmail.com; filonenko@imbg.org.ua  
 
Identification and characterization of novel biomarkers as potential therapeutic and 
diagnostic targets in ovarian cancer is very important due to poor prognosis of this deadly 
disease. In recent publications, phosphate transporter NaPi2b was considered as potential 
biomarker for breast, thyroid and ovarian cancer. Sodium dependent phosphate 
transporter NaPi2b is coded by the SLC34A2 gene and involved in maintaining of 
phosphate homeostasis in human body. Mutations in this gene and its aberrant expression 
are associated with several diseases including cancer. However, data about NaPi2b 
mRNA expression in different histomorphological types of cancer are controversial and 
restricted. 
The main purpose of this study was to estimate the SLC34A2 gene expression in ovarian 
cancer tumors of different histomorphological types and differentiation grades. 
We investigated SLC34A2 gene expression level in serous (6), endometrioid (4), 
mucinous (2) benign tumors (6) and normal ovarian tissue (5) using Real-Time PCR 
analysis. Differences in gene expression were calculated as fold changes in gene 
expression in ovarian carcinomas compared to normal ovaries. It was found that 
SLC34A2 gene was highly overexpressed in endometrioid tumors (20.2-fold increase) 
and serous tumors (116.9-fold increase), but not overexpressed in mucinous tumors 
compared to normal tissue. Benign tumors showed insignificant increase of SLC34A2 
mRNA expression (from 1 to 6-fold increase), except one case of mucinous cystadenoma 
(396.9-fold increase). Analysis of SLC34A2 gene expression according to tumor 
differentiation grade (low, moderate or high) in the endometrioid and serous histological 
types of ovarian cancer showed that SLC34A2 tend to reduce level of gene expression in 
less differentiated tumors. 
The down regulation of SLC34A2 gene expression may reflect cell dedifferentiation 
during ovarian cancer malignant transformation and could serve as potential marker for 
ovarian cancer diagnosis and prognosis. 
  45
Combination of arginine deprivation and canavanine treatment as 
anticancer approach: study in 3-D culture 
1Vynnytska B., 1Bobak Y., 2Garbe Y., 1Kurlishchuk Y., 2Kunz-Schughart L., 
 1Stasyk O. 
1 Department of Cell Signaling, Institute of Cell Biology, National Academy of Sciences of Ukraine, 
14/16, Drahomanov St. Lviv, Ukraine, 79005 
2 OncoRay, Center for Radiation Research in Oncology, Faculty of Medicine Carl Gustav Carus, TU 
Dresden Fetscherstr. 74, PF 41,01307 Dresden 
bozhena@litech.net; stasyk@cellbiol.lviv.ua  
In vitro cancer cells are thought to be more sensitive than normal ones to the toxic effects 
of arginine deprivation. Unlike normal cells that enter quiescence upon arginine 
limitations and can be recovered by arginine supplementation, some cancer cells are 
unable to do so and exhibit apoptic signs under arginine-deprived conditions. Our data 
suggest that in monolayer culture cancer cells can also be divided into sensitive or 
resistant according to the differences in the cell behavior upon arginine limitation. 
In the present study we applied 3-D culture system to check whether differences in cell 
sensitivity to arginine deprivation revealed in monolayer culture will be preserved during 
culturing in the form of multicellular tumor spheroids. We showed for the first time that 
in 3-D spheroid culture all tested cancer cells (despite their level of sensitivity to arginine 
withdrawal in 2-D monolayer culture) are much more resistant to arginine deprivation 
and retain growth potential even upon prolonged starvation. 
Enhanced resistance of cancer cells to arginine withdrawal in 3-D spheroid culture, which 
most probably will be also well manifested under in vivo conditions, warrant the search 
for the approaches that could be used in combination with arginine starvation to 
accelerate its antineoplastic potency. That is why another task of present study was to 
estimate the antitumor properties and potential clinical efficacy of the combination of 
arginine deprivation and canavanine treatment (shown by us to be efficient in 2-D 
culture, Vynnytska et al., Anticancer Drugs, 2011) in 3-D culture. We demonstrated that 
although in the form of spheroids cells were more resistant to the application of arginine 
deprivation and canavanine treatment than respective monolayers, the proposed 
combinational approach was still efficient in reducing malignant cell growth, survival 
and recovery and retained its selectivity against malignant cells. These data approve 
further development of the combination of arginine deprivation and canavanine treatment 
as anticancer approach and warrant it’s testing in vivo on animal models. 
 
This work was supported by the DAAD scholarship and Grant from the President of 
Ukraine awarded to Vynnytska B.O. 
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Synthesis and optical properties of new class of inorganic optical 
markers based on lanthanides emission for bio-medical applications  
 
Podhorodecki A., Sojka B., Banski M., Misiewicz J. 
Institute of Physics, Wroclaw University of Technology,  
Wybrzeze Wyspianskiego 27, 50-370 Wrocław, Poland  
artur.p.podhorodecki@pwr.wroc.pl 
 
Introducing to medicine and biology concept of optical markers in tremendous way has 
changed the recent status of these two important disciplines. This was mainly due to 
strong development in imaging techniques which recently allow us to investigate both 
static as well dynamic properties of living cells, their components and their interactions 
with external factors or to investigate their response on drugs treatments.    
However, recently used molecular markers including organic dyes, fluorescent proteins 
or chelates containing lanthanide ions have several significant limitations. Most of them 
emit light in visible spectral range, the emission is weak and characterize by efficient 
bleaching and blinking, obtaining varieties of colors is limited and needs to introduce 
different markers simultaneously, emission decay times are very short in most of the 
cases (ns) and many others. One of the alternatives for molecular markers is inorganic 
quantum dots (i.e. CdSe, CdS), which are recently in common use, in many academic 
works. However, even if they are much better from physico-chemical point of view, from 
the application point of view at this moment they are rather useless. This is mostly due to 
the fact that they are toxic from the definition and all these advantages are not worth to be 
used in the view of high risk during in vivo imaging and not know side effects caused by 
using these markers. 
One of the solution combining advantages of both concepts [molecular markers and 
quantum dots] is to make nontoxic inorganic nanocrystals doped by lanthanide ions. 
These markers except close to zero toxicity are characterized by emission or excitation in 
infrared spectral range and by long emission decay times (s or seconds). This strongly 
increases penetration depth of the light and improves emission signal quality. Both facts 
have strong consequences for application potential of these markers. 
In this work, we will present results obtained for different inorganic markers doped by lanthanide 
ions [Au, Tb, ND, God]. All samples have been obtained by modified in our group co-
thermolysis technique and characterized by many different structural and optical techniques. The 
aim of this work was to design and to synthesize these markers and to understand physical 
processes responsible for their emission and to optimize these processes to the physical limits. 
For this purpose, emission, absorption, emission decay times, micro-Raman, FTIR 
spectroscopies have been done for samples obtained in function of many technological 
parameters like ions concentration, core-shell architecture or different combinations of 
lanthanides in one nanocrystal. 
 48 
Role of Wnt11 in regulating Alveolar Type II (ATII) differentiation: 
evidence from clinical samples and a three-dimensional lung tissue 
model 
Bartis Domokos, Pongrácz Judit E. 
 
Department of Medical Biotechnology, University of Pécs, Hungary  
12 Szigeti ut, H-7524, Pécs, Hungary 
domokos.bartis@aok.pte.hu 
Adult stem cells are in the forefront of interest for lung tissue regeneration therapies in 
diseases resulting in excessive lung injury. Progenitors that are vitally important for 
airway repair of alveolar type I (ATI) cells which form the primary gas-exchange surface 
of the alveoli, are cells designated as alveolar type II (ATII) which can flexibly turn into 
ATI cells on physiological demand. Factors that can regulate ATII differentiation would 
have particularly high importance in regeneration therapy by increasing the number of 
ATII cells thus the regeneration potential of injured lung tissue. Since primary lung 
epithelial cells lose ATII characteristics in conventional 2-dimensional (2D) cultures, the 
construction of an in vitro human pulmonary 3-dimensional (3D) tissue-model was 
imperative to investigate and identify such factors.   
A 3D micro-tissue model consisting of commercially available human adult primary cells 
has been set up to determine factors regulating ATII differentiation. Cellular 
differentiation factors in the micro-tissue model were determined using quantitative 
reverse-transcription polymerase chain reaction analysis, histology, and immuno-
fluorescence microscopy. 
Pulmonary epithelial cells in the environment of the micro-tissue model regain and 
maintain cellular differentiation of the ATII phenotype, as suggested by morphological 
changes as well as increased expression of differentiation markers Aquaporin-3, Thyroid 
transcription factor-1 (TTF-1) Surfactant proteins A and C, and E-cadherin. Furthermore, 
our studies provide the first evidence that Wnt11 is one of the main regulators of ATII 
type differentiation and added Wnt11 can increase expression of the above ATII markers. 
In contrast, silencing of Wnt11 resulted in decreased expression level of ATII markers 
and elevated levels of epithelial-mesenchymal transition (EMT) markers S100A4 and N-
cadherin. Consistent with the findings in the tissue model, Wnt11 treatment of surgical 
lung tissue samples resulted in the up-regulation of ATII markers.  
The 3-dimensional tissue model is highly applicable for studying intercellular 
interactions in the lung. In this easy maintained and flexible tissue system Wnt11 was 
identified as a factor that regulates ATII differentiation. This finding may designate 
Wnt11 as a potential therapeutic target, which enhances the repair potential of pulmonary 
epithelium.  
  49
Differential human cancer cells sensitivity to individual amino acid 
deprivation 
1Kurlishchuk Y., 1Vynnytska B., 1Bobak Y., 2Dittfeld C., 2Kunz-Schughart L., 
1Stasyk O. 
1 Department of Cell Signaling, Institute of Cell Biology, National Academy of Sciences of Ukraine, 
14/16, Drahomanov St. Lviv, Ukraine, 79005 
2 OncoRay, Center for Radiation Research in Oncology, Faculty of Medicine Carl Gustav Carus, TU 
Dresden 
stasyk@cellbiol.lviv.ua  
In this work we aimed to compare the effect of starvation for essential amino acids 
leucine, lysine and methionine with the lack of arginine (shown by us to be also essential 
for tumor cells in vitro; Bobak et al. Cell Biol Int, 2010) on cancer cells in 2-dimensional 
(2-D) and 3-dimensional (3-D) cultures. For this purpose, two human cell lines that 
differed in response to arginine deficiency in 2-D culture were chosen. Hepatocarcinoma 
cells HepG2 were considered sensitive to arginine deprivation due to the time-dependent 
apoptosis induction and loss of growth recovery after starvation. Contrary, lung 
adenocarcinoma cells A549 were referred as resistant because they retained ability for 
proliferation after durable arginine deficiency and showed no signs of apoptosis upon 
starvation. 
It was shown that the absence of each of the chosen amino acids inhibited proliferation of 
tested cells in 2-D culture. Moreover, the lack of leucine or lysine did not influence cell 
viability during the whole experiment. By contrast, methionine starvation induced cell 
death already after 2 days of incubation. The deficiency of leucine or lysine had little 
effect on growth restoration ability of both lines tested and cells exhibited regrowth even 
after 3 days of starvation. The absence of methionine had the most prominent influence 
on malignant cell lines. Thus, HepG2 cells did not restore their proliferation already after 
1 day of methionine starvation, whereas for A549 cells the time-dependent decrease of 
tumor cells response growth restoration potential was observed.  
In order to evaluate tumor cells response to amino acids deprivation in 3-D culture, we 
investigated the effects of their limitation on the formation and growth of tumor 
spheroids. It was demonstrated that arginine deficiency completely prohibited 
aggregation of A549 cells, while HepG2 cells formed cell clusters under the same 
conditions, although of smaller size when comparing with control. The lack of leucine, 
lysine or methionine did not prevent aggregation of neither tested cells. In contrast with 
2-D models, spheroids of both A549 and HepG2 cells were able to rescue growth even 
after prolonged (10 days) starvation. The molecular reasons for this phenomenon remain 
to be elucidated. 
In summary, it was shown for the first time that spheroids of human epithelial cancer 
cells are significantly more resistant to single amino acids limitation in comparison with 
respective monolayer cultures. These data warrant application of the 3-D spheroid culture 
as a reliable testing platform for anticancer therapy based on amino acid restriction. 
 50 
Drug design and structure-functional interrelationships underlying 
in molecular mechanisms of anticancer activity of novel thiazolidone 
derivatives  
1Panchuk R. R., 1,2Chumak V. V., 2Fil’ M. R., 3Havrylyuk D. Ya., 3Lesyk R. B., 
1,2Stoika R. S. 
1 Institute of Cell Biology, NAS of Ukraine,  
14/16, Drahomanov St. Lviv, Ukraine, 79005 
2 Ivan Franko Lviv National University,  
1, University Str, Lviv, Ukraine 
3 Danylo Halytsky Lviv National Medical University,  
69, Pekarska St. Lviv, Ukraine, 79010 
 rpanchuk@ukr.net; dr_r_lesyk@org.lviv.net; stoika@cellbiol.lviv.ua  
Cancer chemotherapy represents a relevant challenge for chemists and oncologists. Thiazoles 
and thiadiazoles are useful heterocyclic compounds possessing numerous treatment actions 
including the anticancer one. Over 5000 novel thiazolidone derivatives were synthesized at 
Danylo Halytsky Lviv National Medical University, and three of them – Les-3120, Les-3166 and 
Les-3372 – were selected at National Cancer Institute (USA) as the most effective in inhibiting 
growth of carcinoma and leukemia cell lines. However, molecular mechanisms of their action 
were not studied. 
Here we demonstrated that these compounds (5 uM, 24 h) caused splitting of anti-apoptotic 
PARP-1 and DFF45 proteins involved in DNA reparation. Their cleavage is mediated by the 
effector caspases-7 and -3 whose level was increased under action of mentioned drugs. However, 
while Les-3120 induced activation of these caspases in 12h, Les-3372 action was marked only in 
24h. Les-3120 and Les-3166 also activated caspase-8 involved in receptor-mediated apoptosis 
and subsequent cleavage of Bid protein in 12h, while Les-3372 did not possessed such activities. 
However, Les-3372 induced activation of initiator caspase-9, which is key protein in 
mitochondria-related pathway of cell death, and release of pro-apoptotic protein AIF from 
mitochondria to cytosol. Thus, despite similar IC50 (5 uM) towards tumor cells, selected 
thiazolidone derivatives differ significantly in molecular mechanisms of their action: Les-3120 
and Les-3166 induce receptor-mediated apoptosis, while Les-3372 switches on cell death via 
mitochondrial pathway.  
Taking into account these data, an idea appeared to combine these unique features of Les-3120 
and Les-3372 in one molecule. To reach that goal, in silico design of novel anticancer drugs was 
performed and two novel isomeric compounds, Les-3661 (4-subsituted thiazolidone) and Les-
3713 (2-substituted thiazolidone) were synthesized. Their anticancer activity was studied by 
annexin V/propidium iodide assay, DAPI staining and Western-blot analysis. We found that both 
Les-3661 and Les-3713 were 5-10 times more active towards leukemia and carcinoma cell lines 
comparing the parental compounds. Location of substitution of active groups in thiazolidone 
plays crucial role in mechanisms of action of novel “hybrid” molecules. Les-3661 is the most 
active among known thiazolidones, and its IC50 0.5 uM is comparable with doxorubicin. It 
induced receptor-mediated apoptosis via activation of initiator caspases-8 and -10 in 6h, while its 
isomeric form Les-3713 possessed 2 times weaker cytotoxic effect and activated initiator and 
effector caspases only in 12h. Thus, combining active groups of two different anticancer drugs in 
one molecule dramatically increased their activity towards specific cancer cell targets. 
 
  51
Effect of autophagy modulation on human ovarian carcinoma 
response to arginine deprivation 
1Shuvayeva G. Y., 1Groholska O. B., 1Igumentseva N. I., 2Isidoro C., 1Stasyk O. V. 
1Department of Cell signaling, Institute of Cell biology, National Academy of Sciences of Ukraine, 
14/16, Drahomanov St. Lviv, Ukraine, 79005 
2 Laboratory of Molecular Pathology and Nanobioimaging, Department of Medical Science, Amedeo 
Avogadro University, 6 Via Duomo Vercelli, Novara, Alessandria, Italy. 13100 
shuvayeva@cellbiol.lviv.ua 
 
Autophagy is a major mechanism of cellular protein and organelle recycling, induced in 
response to nutrient starvation or metabolic stress. The role of autophagy in cancer 
progression and in response to various therapies is a topic debate in current biomedical 
science.  
Recently we showed that deprivation for such amino acids as arginine, lysine, leucine or 
methionine, strongly induces autophagic response in the human ovarian carcinoma 
SKOV3 cells, highly resistant to this metabolic stress. Arginine (ARG) deprivation 
achieved with recombinant ARG-degrading enzymes is currently considered as 
anticancer therapy. On the model of SKOV3 cells, we addressed the question, whether 
autophagy plays a pro-survival role upon ARG starvation and whether its modulation 
may enhance the therapy. 
For this, we examined cell viability upon autophagy inhibition or over-induction in ARG-
free medium and ability to restore proliferation upon ARG re-supplementation. 
Antimalarial and potential anticancer drug chloroquine (CQ) and 3-methyladenine (3-
MA) were utilized as autophagy inhibitors, whereas resveratrol (RV) was applied as an 
autophagy-enhancing compound. In addition, we examined the effect of taxol, a drug 
currently used to treat human ovarian carcinomas, on cell survival under ARG 
deprivation and upon modulation of autophagy.  
We demonstrated that autophagy over-induction by RV did not affect SKOV3 cells 
viability upon ARG deprivation. However, ARG re-supplementation inhibited of 
autophagy with 3-MA or CQ and decreased cell viability and proliferation. This effect 
was dramatically enhanced upon taxol treatment. Upon combined treatment with CQ and 
taxol in ARG -free medium, SKOV3 cells lost their ability to restore proliferation in 
ARG supplemented medium already after 2 days of incubation. We also observed that 
inhibition of autophagy upon cultivation in complete medium (either pharmaceutically or 
via siRNA silencing of autophagic protein Beclin 1) dramatically affected SKOV3 cell 
viability.  
Although ovarian carcinomas were not considered as potentially sensitive to the therapy 
based on ARG deprivation, it was recently reported that tumors relapsed after treatment 
with platinum compounds concomitantly become sensitive to ARG deprivation due to the 
loss of the expression of ARG biosynthetic enzyme, argininosuccinate synthetase (ASS). 
Our results point at potential efficacy of the combinational approach based on ARG 
deprivation, autophagy inhibition and taxol treatment as a second line therapy for such 
hard to cure ovarian carcinomas. 
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Serial Analysis of Gene Expression revealed CHI3L1 and CHI3L2 among the genes with 
the most pronounced changes of expression in tumor cells (Kavsan et al., 2005). In 
contrast to CHI3L1, which has been characterized as a marker of inflammatory diseases, 
the features of it closest homologue - CHI3L2 were poorly described. Because they are 
closely related in size and sequence to each other, we summarize research on CHI3L1 as 
a background for CHI3L2 investigation. 
CHI3L1 expression is increasing significantly under pathological conditions such as 
inflammation or tumors, notably glioblastoma. It was shown that CHI3L1 stimulates the 
growth of connective tissue cells similarly to IGF-1. This mitogenic activity is mediated 
by signaling through the MAPK and PI-3K cascades (Recklies et al., 2002). 
To examine if CHI3L2 can stimulate the activation of MAPK pathway by 
phosphorylation of Erk1/2 similarly to EGF, we used human embryonic kidney 
(HEK293) and gliobastoma (U373) cell lines which don’t produce endogenous growth 
factors. The results obtained, suggest that Erk1/2 phosphorylation was stimulated in these 
cells following addition of CHI3L2 or CHI3L1 in dose- and time-dependent manner. To 
determine whether CHI3L2 and CHI3L1 can enhance mitogenesis, cell proliferation and 
[3H]thymidine incorporation were evaluated. Unexpectedly, in opposite to CHI3L1, dose 
dependent decreasing of measured parameters was observed in HEK293 and U373 cells. 
In both cell types treatment with CHI3L2 gave more sustained than CHI3L1 MAPK 
activation with prolonged phospho-Erk-1/2 nuclear accumulation in HEK293. Moreover, 
our results indicate that CHI3L2 inhibit proliferative action of CHI3L1 and IGF-1 in 
tested cell lines. 
Activation of the MAPK is a normal response following engagement of growth factor 
receptors. However, the Erk1/2 pathway is frequently subject to inappropriate activation 
in a variety of tumor cell lines and tumor tissue as it was shown here for glioblastoma 
U373 cell line. Transient activation will therefore have very different consequences for 
gene expression compared with sustained activation in the cells of different origin 
because nuclear accumulation of active Erk1/2 will result in phosphorylation of different 
transcription factors. Determination of the cellular response depending on previous 
developmental events that determine which Erk-responsive transcription factors are 
present in the HEK293 and U373 cells is a purpose of further investigations. 
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Uterine cancer is a disease characterized by tumor-specific mutations and dysregulated 
signalling pathways. The characterization of molecular alterations in each single tumor is 
the basis for the development of personalized anticancer therapy. Adaptor/scaffold 
proteins are the key components of signalling networks involved in the control of cell 
physiology. In particular, by binding to numerous effector proteins adaptor/scaffold 
protein Ruk/CIN85 assembles multimeric complexes implicated in regulation of multiple 
cellular functions, including proliferation, adhesion, invasion, and survival. 
Ruk/CIN85 expression in uterine tumours as well as conditionally normal tissues was 
analyzed using Northern- and Western-blot analyses. Serum-starved human cervical 
cancer HeLa cells were treated with 5α-dihydrotestosterone (DHT). Involvement of 
Rukl/CIN85 full-length form in rapid nongenomic effects of androgen was studied using 
Western-blot analysis, immunoprecipitation and confocal microscopy. 
Increase of Rukl/CIN85 mRNA and protein expression levels was revealed in uterine 
tumours as compared to conventionally normal surrounding tissues. The characteristic 
feature of Ruk/CIN85 forms expression patterns in control tissues as well as in benign 
tumours was a high content of high-molecular-weight Ruk/CIN85 forms (140 and 130 
kDa), while increase in the content of low-molecular-weight forms (40 and 30 kDa) was 
observed in samples of malignant tumours.  
For the first time, androgen receptor was identified in human cervical cancer HeLa cells. 
It was established that the content of full-length Rukl/CIN85 form in Triton-X-100-
soluble fraction of untreated human cervical adenocarcinoma HeLa cells in logarithmic 
growth phase was very low, whereas stimulation of cells with DHT resulted in its up-
regulation. DHT-dependent complex formation between Rukl/CIN85 and androgen 
receptor as well as the role of Rukl/CIN85 in rapid non-genomic effects of androgen 
receptor was revealed using confocal microscopy, immunoprecipitation and Western-blot 
analysis. 
The obtained results suggest that up-regulation of full-length form expression level as 
well as involvement of Rukl/CIN85 in rapid nongenomic effects of androgen might 
contribute to uterine carcinogenesis. 
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Background. The signaling components upstream and downstream of the protein kinase 
mammalian target of rapamycin (mTOR) are frequently altered in a wide variety of 
human diseases. Upstream of mTOR key signaling molecules are the small GTPases Ras 
and Rheb, PI3K, PKB, known to be deregulated in many human cancers. Mutations in 
the mTOR pathway component genes TSC1, TSC2, LKB1, PTEN, VHL, NF1 and PKD1 
trigger the development of the syndromes Tuberous sclerosis, Peutz-Jeghers, Cowden, 
Bannayan-Riley-Ruvalcaba, Lhermitte-Duclos disease, Proteus syndrome, von Hippel-
Lindau disease, Neurofibromatosis type 1, and polycystic kidney disease, respectively. 
Recently, it has been recognized that mTOR is regulated by TNF-α and Wnt, both of 
which have been shown to play critical roles in the development of many human 
neoplasias. In addition to all these human diseases, the role of mTOR in Alzheimer´s 
disease, cardiac hypertrophy, obesity and type II diabetes is discussed. So, it is the hope 
of investigators and patients alike that a more detailed understanding of the mTOR 
signaling cascade will lead to new therapies for many different human diseases. 
mTOR exists in two functionally and structurally distinct complexes, mTOR complex 1 
(mTORC1) and mTOR complex 2 (mTORC2). mTORC1 contains raptor, mLST8 and 
PRAS40 and controls cell growth via a rapamycin-sensitive signaling branch regulating 
translation, transcription, nutrient uptake, ribosome biogenesis, and autophagy. mTORC2 
contains protor, rictor and sin1 proteins and controls the organization of the actin 
cytoskeleton through a rapamycin-insensitive signaling branch.  
Objectives. The architecture of mTORC2 is discussed in the context of TORC2 assembly 
and regulation. We have focused on the characterization of mTORC2 architecture, 
notably, on the characterization of the interactions between mTOR and rictor. To analyze 
the specificity of these interactions prompted us to develop monoclonal antibodies, which 
would specifically recognize rictor (Mab against mTOR were produced previously).  
Results. Recombinant His-GST-rictor/Nterm was used as an antigen and in hybridoma 
screening procedures. Generated antibodies work efficiently in various immunoassays, 
including ELISA, Western blotting and immunoprecipitation. Furthermore, the 
immunoblotting of the mTOR immune complexes with Mab against rictor clearly 
indicated that rictor is efficiently co-immunoprecipitated with mTOR in HEK 293 cells. 
Intriguingly, binding partners were not immunoprecipitated in viсe versa experiment.  
Conclusion. Data presented in this work indicate that mTOR interacts with rictor in vivo. 
In addition, N-terminal domain of rictor may implements an interaction with mTOR.  
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Background: In the therapeutic management of breast cancer patients’ evaluation of the 
bone status is crucial, as it allows early detection of bone metastases, which have 
substantial influence on the patients’ quality of life and on the treatment of choice 
administered. 
Aim: The aim of the present study was to retrospectively compare the diagnostic 
accuracy of the PET/CT and bone scintigraphy (BS), which is the current gold-standard 
method for the detection of bone metastases in breast cancer patients. The relationship 
between FDG uptake, CT morphology and abnormal findings on BS was also analyzed. 
Methods: The inclusion criteria for patients were: BS and FDG PET/CT examinations 
performed within 60 days, available imaging datasets and verified bone status, which was 
confirmed either by corresponding findings of the baseline BS and PET/CT 
examinations, or by follow up imaging examinations (BS, PET/CT, x-ray, CT, MR) 
corroborating the original findings. Patients, who were considered metastasis free, were 
followed clinically for at least two months. Additionally, tumor marker levels were also 
measured.  
Based on PET/CT a total of 235 lesions were analyzed, out of which 164 were 
concordant with BS. 
Results: During the past 26 months 1546 breast cancer patients were examined with 
PET/CT at our center, and 98 of them met the inclusion criteria. Bone metastases were 
verified in 35 patients. The sensitivity of PET/CT and BS was 97.14% and 91.43%, 
respectively, whereas the specificity of methods was 96.83% (PET/CT) and 85.71% 
(BS). Positive predictive values were 94.44% (PET/CT) and 78.05% (BS), whereas 
negative predictive values were 98.39% (PET/CT) and 94.74% (BS). The overall 
accuracy of PET/CT and BS was 96.94% and 87.76%, respectively. 
On lesion-based analyses significant difference were observed between FDG uptake and 
CT morphology (p<0.0001), and diameter of metastases. We also find an unexpected 
difference between activity on BS and CT morphology; lytic lesions have higher activity 
on BS than sclerotic ones (p<0.0001). 
Conclusions: Our results suggest that the diagnostic value of PET/CT to detect bone 
metastases in breast cancer patients is higher than that of BS. PET/CT is superior to BS 
as it also provides full staging, although at a substantially higher cost. 
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Background: Nowadays we can observe increasing interest in the possible application of 
carbon nanospheres, known as fullerenes, in biomedicine. С60 fullerenes are 
nanodimensional molecules consisting of 60 atoms of carbon. С60 fullerene molecules act 
as prooxidant due to the formation of ROS after UV/VIS photo excitation. Since 
generation of ROS is known to be involved in the development of apoptotic cell death, 
using of fullerenes for cancer photodynamic therapy seems to be promising. It is known 
that ROS generally led to a rapid apoptotic outcome with mitochondrial damage and 
release of cytochrome c into the cytosol. The appearance of cytosolic cytochrome c 
triggers an apoptotic response via the sequential activation of caspase-9 and caspase-3. 
Nevertheless, the mechanism of C60 fullerene-induced cell death in oncotransformed cells 
has been poorly studied. 
Aim: The aim of the present work was to study the markers of mitochondria-dependent 
apoptosis in transformed T cells irradiated with UV/VIS light in the presence of C60 
fullerenes. 
Materials and methods: Cell viability was assessed by the MTT reduction assay. Level of 
cytochrome c in cytosolic fraction and caspase-3 activation was analyzed by Western-
blot analysis. Colloidal aqueous solutions of С60 fullerenes were prepared in Technical 
University of Ilmenau (Germany). 
Results: The cytotoxic effect of C60 fullerene was detected in human transformed T cells 
(Jurkat cell line) after irradiation with UV/VIS light (λ=320-600 nm). After short-time 
irradiation of Jurkat cells pre-incubated for 1 h with 5·10-5 М С60 fullerene cell viability 
was decreased by 50±4% after 6 h incubation. The cytotoxic effect of photoexcited C60 
fullerene in transformed cells was proved to be dose- and time-dependent. There was no 
significant change in the level of cytosolic cytochrome c after UV/VIS illumination, but a 
substantial increase was observed by combined action of С60 fullerene and UV/VIS 
illumination after 1 h incubation. UV/VIS irradiation alone is followed by caspase-3 
activation in Jurkat cells at 6 and 24 h. However, in cells, irradiated with UV/VIS light in 
the presence of C60 fullerene, caspase-3 processing was dramatically intensified – the 
content of 17 and 19 kDa intermediate cleavage products was increased already at 6 h. 
After 24 h, caspase-3 activation was increased by 20 fold as compared to control. 
Conclusion: Photo excited C60 fullerene causes apoptotic cell death accompanied by 
cytochrome c release into the cytosol and subsequent caspase-3 activation in transformed 
T cells. 
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It was shown previously that certain cancers may be auxotrophic for a particular amino 
acid, and amino acid deprivation seems to be one of the methods to treat such tumors. 
Arginine is a semi-essential amino acid for normal cells in adult humans but it is essential 
for rapidly proliferating tumor cells. Thus arginine deprivation, alone or in combination 
with other chemotherapeutics, may offer a new powerful tool in the control of tumor 
growth. 
Our preliminary data indicate that arginine-deprivation in monolayer culture (obtained 
via addition of recombinant arginase), unlike lysine-deprivation, caused significant 
decrease in human glioma U251 cells migration and invasiveness. Using confocal and 
scanning electron microscopy we have also observed evident changes in cell 
morphology: the zone of the dense lamellipodial network at the leading edge was reduced 
to half in width in cells incubated without arginine relative to cells grown on complete 
medium. The cells grown in arginine-deprived medium were more elongated that the 
cells cultured in lysine-deprived and control media and had reduced potential to form 
colonies. 
We suggest that this effect of arginine deprivation is connected with changes in the 
polymerization of β-actin. To confirm this hypothesis, we performed a biochemical 
fractionation of lysates from U251 glioma cells by differential centrifugation. We found 
that the major difference between extracts of cells incubated in arginine-sufficient and 
deprived media was observed at the highest sedimentation speed, which separates F- and 
G-actin. For arginine-deprived cells (but not lysine-deprived) we found dramatic 
reduction in the level of polymeric fraction of β-actin. This effect was reversed upon re-
supplementation of the medium with arginine. 
The current study takes the first steps toward uncovering the mechanism behind arginine-
dependent regulation of neuronal cell motility and invasiveness and metastatic potential, 
issues not addressed in the previous studies. The obtained results point at profound 
alterations in actin cytoskeleton organization, probably also associated with arginylation 
of actin, a process known to regulate actin cytoskeleton remodeling, and are very 
important for design of efficient anticancer therapies based on arginine deprivation. 
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Quantitative analysis of carbohydrates has significant importance for diagnosis and 
treatment of different diseases connected with metabolism disorders. Measurement of 
glucose, major metabolite, is critical for people who suffer from diabetes. Determination 
of lactose is also of interest in medicine. For example, excessive amount of lactose in 
blood (>600 mM) can indicate gastrointestinal malignancy. This type of cancer is widely 
spread in the world. Abnormal amount of lactose, sucrose and maltose in human fluids 
indicates different metabolism disorder such as carbohydrate intolerance etc.  
The great demand for the determination of carbohydrates in human fluids (blood, urine 
etc.) has led to the development of a variety of analytical methods. The majority of these 
methods (spectrophotometry, chromatography etc.) is tedious and time consuming, may 
require expensive equipment, in addition to considerable technical skills. In this context, 
biosensors have the potential to overcome disadvantages of conventional methods: they 
are simple, accurate, high specific, sensitive, fast, convenient, rather cheap and small 
devices. Among different biosensor systems multibiosensors are especially attractive 
because they enable simultaneous measurement of several analytes in a single sample.  
The main aim of our work was improvement of analytical characteristics of new enzyme 
conductometric multibiosensor for simultaneous quantitative analysis of glucose, 
maltose, lactose and sucrose in liquid samples. To create bio-selective membranes for 
analysis of maltose, lactose and sucrose three enzymes (glucose oxidase, mutarotase and 
suitable glycosidase) were immobilized on electrodes using glutaraldehyde. Single-
enzyme glucose oxidase membrane was applied for glucose determination. The optimal 
concentrations of enzymes and their ratio in bio-selective membranes were found. 10 mM 
phosphate buffer solution, pH 6.0 as working solution proved to be optimal for 
functioning of multibiosensor. The developed sensor system showed a linear response to 
carbohydrates within the concentration range from 0.001 to 1.5-10 mM depending on 
enzyme composition and thickness of bio-selective membrane. The time of carbohydrates 
determination was 1-2 min. The adapted multibiosensor is characterized by high 
operational stability; show good selectivity and high signal reproducibility. Proposed 
multibiosensor can be applied in medical diagnostics. 
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Background. Bcr-Abl, the product of a chromosomal translocation t(9;22), has been 
demonstrated to be a key protein responsible for the pathogenesis of  Ph-positive 
leukemia. Depending on the breakpoint region of the bcr gene, three Bcr/Abl proteins 
have been observed: p190 Bcr-Abl, p210 Bcr/Abl, and p230 Bcr-Abl. The only structural 
difference between various Bcr-Abl chimeras is the presence of Dbl homology (DH) and 
pleckstrin homology (PH) domains in p210 Bcr-Abl and p230 Bcr/Abl.  p210 Bcr-Abl 
and p230 Bcr-Abl are responsible for chronic myelogenous leukemia while p190 Bcr-Abl 
is associated with more aggressive acute lymphoid leukemia suggesting the important 
role of the DH and PH domains in leukemogenesis.  Our resent data demonstrated that 
Bcr-Abl PH domain binds a number of proteins including phospholipase Cε (PLCε).  
However, the signaling consequences of such association remain unclear. Previous 
studies have shown that PLCε is both target and regulator of the Ras superfamily of 
GTPases, key players in p210-BCR-ABL-dependent leukemogenesis. Also it has been 
shown that PLCε transcripts are not expressed in normal peripheral blood leucocytes. 
However, the role of a PLCε in leukemia progression is not clear yet.  
Aims. The aim of this study is to analyze the relationship between PLCε expression and 
both the presence and the type of Bcr/Abl rearrangement in patients with 
myeloproliferative disorders (MPDs).  
Results. We have analyzed PLCε expression in 12 patients with different MPDs. The 
cDNA was obtained from the peripheral blood leukocytes by one-step RT-PCR using 
total RNA as template. PLCε expression and the presence and the type of Bcr/Abl 
transcript were identified using gene specific primers. PLCε expression was detected 
using oligonucleotide primers specific to Ras/Rap-associating (RA) domains that are a 
unique distinguishing feature of PLCε among other phospholipase C isozymes.  
The specificity of PCR product was confirmed by direct sequencing. Bcr/Abl 
rearrangement was detected by nested RT-PCR analysis. Our data showed that all 
patients have detectable level of PLCε expression and 9 of them demonstrate the 
presence of p210 Bcr/Abl translocation.  
Conclusion. Our results suggest that expression of PLCε in peripheral blood leucocytes 
of patients with MPDs correlates with the presence of p210 Bcr/Abl. Therefore, the PLCε 
expression in leukemia patients could be a marker of oncogenic transformation during 
CML development. Further analysis of a molecular mechanism underlying a crosstalk 
with Bcr/Abl and PLCε signaling may lead to the development of novel therapeutic 
angles for Ph-positive leukemia. 
